Liver Cancer Trial, Recruiting NCT06777485 Sponsor: Anhui Provincial Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06777485
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older, of any gender
  • People who have been diagnosed with one of the following liver cancers — hepatocellular carcinoma, intrahepatic cholangiocarcinoma, mixed hepatocellular-cholangiocarcinoma, or metastatic hepatocellular carcinoma — either through imaging and laboratory tests (without surgery) or through tissue examination after surgery
  • People who are willing to sign a consent form, attend follow-up appointments, and provide blood samples and any leftover tissue from surgery

Who may not be able to join:

  • People with serious conditions affecting the brain or nervous system, lungs, immune system, or kidneys, or those who have been taking immune-suppressing medications long-term, or who have a severe ongoing infection
  • People with active heart or blood vessel disease, including a stroke or heart attack within the past 6 months, unstable chest pain, moderate-to-severe heart failure, or a serious irregular heartbeat requiring medication
  • People who are currently pregnant or breastfeeding
  • People who are already taking part in another treatment clinical trial where details about the treatment cannot be clearly identified or recorded

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13836135864

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Anhui Provincial Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
1 January 2035

Where this trial is recruiting

🇨🇳 China

Primary endpoints

OS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov